Alzheimer's Drugs Found Ineffective, Dangerous
|
A large-scale clinical trial published in the New England Journal of Medicine and funded by the National Institute of Mental Health (NIMH) shows that Zyprexa, Risperdal and Seroquel, antipsychotics prescribed to treat delusions and aggression associated with Alzheimer's Disease in as many as one-fourth of nursing home patients, are not significantly more effective than placebos.
The double-blind trial monitored 421 patients taking either medication or a placebo for nine months. While 30 percent of patients taking medication did show an improvement in symptoms, so did 21 percent of those taking the placebo. Additionally, about 80 percent of patients ultimately stopped taking their pills after several weeks citing ineffectiveness or side effects including worsening confusion or trouble walking. Given these adverse effects--which also include an increased risk of pneumonia, heart attack or death--and the conditions under which most patients take the drugs, such findings are significant. Says lead researcher Dr. Lon Schneider: "Patients are put on these kinds of medications and not particularly monitored and treated for indefinite periods of time...That just maximizes risk."Read more: Antipsychotic Medications Used to Treat Alzheimer's Patients Found Lacking ABSTRACT: Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease SHARE:
Posted In: Alzheimer's Disease | Tags: Drugs | Antipsychotics | Posted by FindCounseling.com Staff on October 12, 2006 at 05:57 AM | Permalink |
AboutThis page contains a single entry from Psychology Briefs, the FindCounseling.com Blog. The previous post was Mental Illness May Keep Pregnant Women Smoking. The next post is Autistic Children Lag in Distinguishing Living vs. Non-Living Things. Many more can be found on the main index page or by looking through the Psychology Research Archives. Subscribe              ATOM RSS |
